From: Tryptophan catabolism and immune activation in primary and chronic HIV infection
Primary HIV infection N = 14 | Early presenters N = 16 | Late presenters N = 19 | ||||
---|---|---|---|---|---|---|
ρ | pvalue | ρ | pvalue | ρ | pvalue | |
CD8 + CD38 + HLA-DR+ | ||||||
Baseline | .867 | .002 | .534 | .033 | .311 | .260 |
After 6 months of cART | −.417 | .265 | .670 | .006 | .152 | .676 |
After 12 months of cART | −.800 | .104 | .451 | .164 | .145 | .670 |
CD4 + CD38 + HLA-DR+ | ||||||
Baseline | .267 | .488 | .689 | .003 | .530 | .051 |
After 6 months of cART | −.410 | .273 | .711 | .003 | .527 | .117 |
After 12 months of cART | −.872 | .054 | .679 | .022 | .045 | .894 |
ΔCD8 + CD38 + HLA-DR+ | ||||||
After 6 months of cART | .833 | .010 | .086 | .771 | .017 | .966 |
After 12 months of cART | .900 | .037 | .345 | .328 | −.041 | .905 |
ΔCD4 + CD38 + HLA-DR+ | ||||||
After 6 months of cART | .167 | .693 | .530 | .051 | .250 | .516 |
After 12 months of cART | .900 | .033 | .600 | .067 | .273 | .446 |